IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 214 filers reported holding IMMUNOMEDICS INC in Q3 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $805,000 | +32.8% | 9,474 | -44.6% | 0.00% | 0.0% |
Q2 2020 | $606,000 | +224.1% | 17,106 | +23.1% | 0.00% | +200.0% |
Q1 2020 | $187,000 | -53.1% | 13,900 | -26.5% | 0.00% | -50.0% |
Q4 2019 | $399,000 | -1.2% | 18,900 | -38.2% | 0.00% | +100.0% |
Q3 2019 | $404,000 | -59.2% | 30,600 | -57.2% | 0.00% | -75.0% |
Q2 2019 | $991,000 | -29.7% | 71,451 | -2.6% | 0.00% | -33.3% |
Q1 2019 | $1,409,000 | +28.9% | 73,351 | -4.3% | 0.01% | 0.0% |
Q4 2018 | $1,093,000 | -29.5% | 76,651 | +3.0% | 0.01% | -14.3% |
Q3 2018 | $1,550,000 | +1.5% | 74,451 | +15.3% | 0.01% | 0.0% |
Q2 2018 | $1,527,000 | +1227.8% | 64,551 | +136.5% | 0.01% | +600.0% |
Q1 2014 | $115,000 | -8.7% | 27,300 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $126,000 | -33.3% | 27,300 | -10.5% | 0.00% | 0.0% |
Q3 2013 | $189,000 | – | 30,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |